未经治疗的慢性乙型肝炎病毒感染中乙型肝炎e抗原清除:系统综述与荟萃分析
该系统综述与荟萃分析纳入26项队列研究,评估未经治疗的慢性HBV感染者HBeAg清除率。汇总清除率为6.46/100人年(95%CI 5.17-8.08),荟萃回归显示年龄较大和欧洲研究地区与更高清除率相关。
要点
- 未经治疗的慢性HBV感染者HBeAg汇总清除率为6.46/100人年(95%CI 5.17-8.08)。
- 按地区,欧洲清除率13.67/100人年(95%CI 11.21-16.66;4项研究)最高。
- 年龄较大和欧洲研究地区与更高HBeAg清除率相关。
核心结论
- 自发性HBeAg清除的发生率为6.46/100人年。
- 地区和年龄组的差异可能反映流行病学、免疫学或HBV基因型相关差异。
研究设计与样本
- 系统综述与荟萃分析,纳入26项报告未经治疗慢性HBV感染者HBeAg清除的队列研究。
- 共筛选10560篇出版物,进行196篇全文分析。
主要发现
- HBeAg清除的汇总率为6.46/100人年(95%CI 5.17-8.08)。
- 荟萃回归显示,参与者年龄较大和欧洲研究地区与更高HBeAg清除率相关。
- 非洲清除率为7.43/100人年(95%CI 6.30-8.75;1项研究)。
- 东地中海地区清除率为3.24/100人年(95%CI 2.61-4.02;1项研究)。
- 欧洲清除率为13.67/100人年(95%CI 11.21-16.66;4项研究);北美为7.34/100人年(95%CI 4.61-11.70;5项研究);西太平洋地区为5.53/100人年(95%CI 4.05-7.55;15项研究)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In people with hepatitis B virus (HBV) infection, persistence of hepatitis B e antigen (HBeAg) is associated with clinical progression and need for treatment. HBeAg loss represents partial immune control and is a critical event in the natural history of chronic HBV. METHODS: We conducted a systematic review and meta-analysis of cohort studies that report HBeAg loss among people with untreated chronic HBV. We evaluated HBeAg loss using a random-effects model and conducted subanalysis on region. RESULTS: We screened 10 560 publications, performed 196 full-text analyses, and included 26 studies for meta-analysis. The pooled rate of HBeAg loss was 6.46/100 person-years (PYs) (95% confidence interval, 5.17-8.08). Meta-regression showed that older age of participants and studies in Europe were associated with higher rate of HBeAg loss. Rates per 100 PYs were 7.43 (95% confidence interval, 6.30-8.75; 1 study) in Africa, 3.24 (2.61--4.02; 1 study) in the Eastern Mediterranean, 13.67 (11.21-16.66; 4 studies) in Europe, 7.34 (4.61--11.70; 5 studies) in North America, and 5.53 (4.05--7.55; 15 studies) in the Western Pacific. CONCLUSIONS: Spontaneous HBeAg loss occurs at a rate of 6.46/100 PYs. Variations by region and age group may reflect epidemiological, immunological, or HBV genotype-related differences.
引用
- Mohareb AM, Liu AF, Kim AY, et al. Clearance of Hepatitis B e Antigen in Untreated Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-analysis. J Infect Dis. 2022. PMID: 35511194. doi:10.1093/infdis/jiac168
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。